1. Home
  2. NVCR vs VRE Comparison

NVCR vs VRE Comparison

Compare NVCR & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VRE
  • Stock Information
  • Founded
  • NVCR 2000
  • VRE 1949
  • Country
  • NVCR Switzerland
  • VRE United States
  • Employees
  • NVCR N/A
  • VRE N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VRE Real Estate Investment Trusts
  • Sector
  • NVCR Health Care
  • VRE Real Estate
  • Exchange
  • NVCR Nasdaq
  • VRE Nasdaq
  • Market Cap
  • NVCR 1.4B
  • VRE 1.4B
  • IPO Year
  • NVCR 2015
  • VRE 1994
  • Fundamental
  • Price
  • NVCR $12.15
  • VRE $15.90
  • Analyst Decision
  • NVCR Buy
  • VRE Buy
  • Analyst Count
  • NVCR 7
  • VRE 5
  • Target Price
  • NVCR $28.79
  • VRE $19.20
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • VRE 675.8K
  • Earning Date
  • NVCR 10-29-2025
  • VRE 10-29-2025
  • Dividend Yield
  • NVCR N/A
  • VRE 2.01%
  • EPS Growth
  • NVCR N/A
  • VRE N/A
  • EPS
  • NVCR N/A
  • VRE N/A
  • Revenue
  • NVCR $630,160,000.00
  • VRE $285,675,000.00
  • Revenue This Year
  • NVCR $6.68
  • VRE $6.63
  • Revenue Next Year
  • NVCR $7.01
  • VRE $1.57
  • P/E Ratio
  • NVCR N/A
  • VRE N/A
  • Revenue Growth
  • NVCR 14.58
  • VRE 5.04
  • 52 Week Low
  • NVCR $10.87
  • VRE $13.69
  • 52 Week High
  • NVCR $34.13
  • VRE $18.85
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 46.57
  • VRE 61.26
  • Support Level
  • NVCR $11.98
  • VRE $15.30
  • Resistance Level
  • NVCR $12.83
  • VRE $16.29
  • Average True Range (ATR)
  • NVCR 0.56
  • VRE 0.31
  • MACD
  • NVCR 0.15
  • VRE 0.05
  • Stochastic Oscillator
  • NVCR 25.49
  • VRE 69.70

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

Share on Social Networks: